Cabatcha, Quelienjane .

HRN: 28-60-34  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/20/2026
CEFUROXIME 500MG (TAB)
02/20/2026
02/27/2026
PO
500 Mg
BID
UTI
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines